Status:
UNKNOWN
Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.
Lead Sponsor:
Mexican Agrupation for Hematology Study
Collaborating Sponsors:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Instituto Nacional de Cancerologia de Mexico
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
15+ years
Brief Summary
Newly diagnosed adults patients with Acute Myeloid Leukemia will be assessed as traditionally by the treating institution using classic clinical, demographic and cytogenetic variables. Complementary m...
Eligibility Criteria
Inclusion
- Newly diagnosed AML
- Over 15 years of age
- Flow cytometry confirmation
- Candidate for treatment (intensive or not intensive)
Exclusion
- Acute Promyelocytic Leukemia
- Mixed phenotype leukemias
- Isolated myeloid sarcoma
- Blastic plasmacytoid dendritic cell neoplasm
Key Trial Info
Start Date :
March 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04311060
Start Date
March 22 2020
End Date
October 31 2025
Last Update
March 17 2020
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Regional de Alta Especialidad Ixtapaluca
Ixtapaluca, Edo Mex, Mexico
2
Hospital Regional de Alta Especialidad Bajío
León, Guanajuato, Mexico
3
Hospital Universitario
Monterrey, Nuevo León, Mexico
4
Imss Umae 25
Monterrey, Nuevo León, Mexico